(2018). Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research Datalink. Int J Cancer. http://doi.org/10.1002/ijc.31143
. M. Greene
First name
M.
Middle name
H.
Last name
Greene
(2018). Cancer Risk in Myotonic Dystrophy Type I: Evidence of a Role for Disease Severity. JNCI Cancer Spectr. http://doi.org/10.1093/jncics/pky052
. (2019). Diabetes, Metformin, and Cancer Risk in Myotonic Dystrophy Type I. Int J Cancer. http://doi.org/10.1002/ijc.32801
. (2019). Benign tumors in myotonic dystrophy type I target disease-related cancer sites. Ann Clin Transl Neurol. http://doi.org/10.1002/acn3.50856
.